COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
T-knife develops TCR‑engineered T cell therapies for solid tumors using a HuTCR transgenic mouse platform to discover fully human TCRαβs, advancing multiple antigen-targeted programs and out-licensing discovery tools.
